U.S. markets close in 4 hours 46 minutes

  • S&P 500

    3,961.04
    -10.05 (-0.25%)
     

  • Dow 30

    33,108.04
    -63.33 (-0.19%)
     

  • Nasdaq

    13,040.67
    -18.98 (-0.15%)
     

  • Russell 2000

    2,183.76
    +25.08 (+1.16%)
     

  • Crude Oil

    60.84
    -0.72 (-1.17%)
     

  • Gold

    1,686.30
    -28.30 (-1.65%)
     

  • Silver

    24.22
    -0.55 (-2.22%)
     

  • EUR/USD

    1.1733
    -0.0039 (-0.33%)
     

  • 10-Yr Bond

    1.7490
    +0.0280 (+1.63%)
     

  • GBP/USD

    1.3722
    -0.0041 (-0.30%)
     

  • USD/JPY

    110.2770
    +0.4690 (+0.43%)
     

  • BTC-USD

    59,030.12
    +965.87 (+1.66%)
     

  • CMC Crypto 200

    1,187.79
    +34.30 (+2.97%)
     

  • FTSE 100

    6,771.16
    +34.99 (+0.52%)
     

  • Nikkei 225

    29,432.70
    +48.18 (+0.16%)
     

Global Licensed Merchandise Market to Reach $338.7 Billion by 2027

ReportLinker
·27 min read

Project Details: - StrategyR - A Trademark of Global Industry Analysts, Inc. - Project Edition: 8. - Influencer Pool: 452. - MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies.

New York, March 30, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Organic Soy Proteins Industry" - https://www.reportlinker.com/p05957182/?utm_source=GNW
In addition to being a global intelligence exchange platform, MarketGlass™ is a powerful knowledge center that delivers dynamic project-focused market intelligence. Client companies will have complete insider access to the project Data stack.
- Interactive peer-to-peer and enterprise-to-enterprise ideation and market intelligence exchange is facilitated via a robust, secure, and validated process. The process draws from uniquely qualified project-specific and geographically focused executives overseeing business development, marketing and sales operations.

  • Trends & Factors - Identifying and validating local trends and factors driving each competitive marketplace. These factors include pricing variances, market trajectories, Covid-19 impact and recovery, locally active leading brands, and other parameters impacting the region in the short to medium term such as supply chain realignments.

  • Mobile Access & App - Our mobile version of the report may be accessed via our mobile app or directly for a full mobile experience.

  • Complimentary Updates - for one year. At least one update in 12-month period is normal and anytime there’s a significant change affecting the market dynamics.

  • Bespoke Updates & Team Collaborations - Clients may build a bespoke version of our report with peers on our MarketGlass™ platform which enables multidimensional data simulations.

  • Knowledge Center - clients have full-stack data access for project data they support or purchase including primary research engagement stats, companies and executives.

Abstract:
- Global Organic Soy Proteins Market to Reach $955.9 Million by 2027
- Amid the COVID-19 crisis, the global market for Organic Soy Proteins estimated at US$354.7 Million in the year 2020, is projected to reach a revised size of US$955.9 Million by 2027, growing at a CAGR of 15.2% over the analysis period 2020-2027. Concentrates, one of the segments analyzed in the report, is projected to record a 14.9% CAGR and reach US$424 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Isolates segment is readjusted to a revised 14.9% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $95.6 Million, While China is Forecast to Grow at 19.8% CAGR
- The Organic Soy Proteins market in the U.S. is estimated at US$95.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$217.6 Million by the year 2027 trailing a CAGR of 19.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.9% and 13.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 12% CAGR.
- Flour Segment to Record 16.1% CAGR
- In the global Flour segment, USA, Canada, Japan, China and Europe will drive the 15.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$69.5 Million in the year 2020 will reach a projected size of US$186.7 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$146.4 Million by the year 2027, while Latin America will expand at a 17.9% CAGR through the analysis period.

- Select Competitors (Total 44 Featured) -

  • Agrawal Oil & Biocheam

  • Biopress S.A.S.

  • Burcon Nutrascience Corporation

  • Devansoy, Inc.

  • Frank Food Products

  • Harvest Innovations LLC

  • Hodgson Mill, Inc.

  • Natural Products, Inc.

  • Puris Proteins, LLC

  • SunOpta, Inc.

  • The Scoular Company




Read the full report: https://www.reportlinker.com/p05957182/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Organic Soy
Proteins by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Organic Soy Proteins by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Organic Soy Proteins by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Concentrates by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 5: World Historic Review for Concentrates by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Concentrates by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Isolates by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Isolates by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Isolates by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Flour by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for Flour by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Flour by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Functional Foods
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 14: World Historic Review for Functional Foods by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Functional Foods by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Infant Formula by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 17: World Historic Review for Infant Formula by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Infant Formula by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Bakery &
Confectionery by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Bakery & Confectionery by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Bakery & Confectionery
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Meat Alternatives
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 23: World Historic Review for Meat Alternatives by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Meat Alternatives by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Dairy
Alternatives by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 26: World Historic Review for Dairy Alternatives by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Dairy Alternatives by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 28: USA Current & Future Analysis for Organic Soy
Proteins by Segment - Concentrates, Isolates and Flour -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 29: USA Historic Review for Organic Soy Proteins by
Segment - Concentrates, Isolates and Flour Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 30: USA 15-Year Perspective for Organic Soy Proteins by
Segment - Percentage Breakdown of Value Sales for Concentrates,
Isolates and Flour for the Years 2012, 2020 & 2027

Table 31: USA Current & Future Analysis for Organic Soy
Proteins by End-Use - Functional Foods, Infant Formula, Bakery &
Confectionery, Meat Alternatives and Dairy Alternatives -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 32: USA Historic Review for Organic Soy Proteins by
End-Use - Functional Foods, Infant Formula, Bakery &
Confectionery, Meat Alternatives and Dairy Alternatives Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 33: USA 15-Year Perspective for Organic Soy Proteins by
End-Use - Percentage Breakdown of Value Sales for Functional
Foods, Infant Formula, Bakery & Confectionery, Meat
Alternatives and Dairy Alternatives for the Years 2012, 2020 &
2027

CANADA
Table 34: Canada Current & Future Analysis for Organic Soy
Proteins by Segment - Concentrates, Isolates and Flour -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 35: Canada Historic Review for Organic Soy Proteins by
Segment - Concentrates, Isolates and Flour Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 36: Canada 15-Year Perspective for Organic Soy Proteins
by Segment - Percentage Breakdown of Value Sales for
Concentrates, Isolates and Flour for the Years 2012, 2020 &
2027

Table 37: Canada Current & Future Analysis for Organic Soy
Proteins by End-Use - Functional Foods, Infant Formula, Bakery &
Confectionery, Meat Alternatives and Dairy Alternatives -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 38: Canada Historic Review for Organic Soy Proteins by
End-Use - Functional Foods, Infant Formula, Bakery &
Confectionery, Meat Alternatives and Dairy Alternatives Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 39: Canada 15-Year Perspective for Organic Soy Proteins
by End-Use - Percentage Breakdown of Value Sales for Functional
Foods, Infant Formula, Bakery & Confectionery, Meat
Alternatives and Dairy Alternatives for the Years 2012, 2020 &
2027

JAPAN
Table 40: Japan Current & Future Analysis for Organic Soy
Proteins by Segment - Concentrates, Isolates and Flour -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 41: Japan Historic Review for Organic Soy Proteins by
Segment - Concentrates, Isolates and Flour Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 42: Japan 15-Year Perspective for Organic Soy Proteins by
Segment - Percentage Breakdown of Value Sales for Concentrates,
Isolates and Flour for the Years 2012, 2020 & 2027

Table 43: Japan Current & Future Analysis for Organic Soy
Proteins by End-Use - Functional Foods, Infant Formula, Bakery &
Confectionery, Meat Alternatives and Dairy Alternatives -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 44: Japan Historic Review for Organic Soy Proteins by
End-Use - Functional Foods, Infant Formula, Bakery &
Confectionery, Meat Alternatives and Dairy Alternatives Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 45: Japan 15-Year Perspective for Organic Soy Proteins by
End-Use - Percentage Breakdown of Value Sales for Functional
Foods, Infant Formula, Bakery & Confectionery, Meat
Alternatives and Dairy Alternatives for the Years 2012, 2020 &
2027

CHINA
Table 46: China Current & Future Analysis for Organic Soy
Proteins by Segment - Concentrates, Isolates and Flour -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 47: China Historic Review for Organic Soy Proteins by
Segment - Concentrates, Isolates and Flour Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 48: China 15-Year Perspective for Organic Soy Proteins by
Segment - Percentage Breakdown of Value Sales for Concentrates,
Isolates and Flour for the Years 2012, 2020 & 2027

Table 49: China Current & Future Analysis for Organic Soy
Proteins by End-Use - Functional Foods, Infant Formula, Bakery &
Confectionery, Meat Alternatives and Dairy Alternatives -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 50: China Historic Review for Organic Soy Proteins by
End-Use - Functional Foods, Infant Formula, Bakery &
Confectionery, Meat Alternatives and Dairy Alternatives Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 51: China 15-Year Perspective for Organic Soy Proteins by
End-Use - Percentage Breakdown of Value Sales for Functional
Foods, Infant Formula, Bakery & Confectionery, Meat
Alternatives and Dairy Alternatives for the Years 2012, 2020 &
2027

EUROPE
Table 52: Europe Current & Future Analysis for Organic Soy
Proteins by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 53: Europe Historic Review for Organic Soy Proteins by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 54: Europe 15-Year Perspective for Organic Soy Proteins
by Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2020 & 2027

Table 55: Europe Current & Future Analysis for Organic Soy
Proteins by Segment - Concentrates, Isolates and Flour -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 56: Europe Historic Review for Organic Soy Proteins by
Segment - Concentrates, Isolates and Flour Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 57: Europe 15-Year Perspective for Organic Soy Proteins
by Segment - Percentage Breakdown of Value Sales for
Concentrates, Isolates and Flour for the Years 2012, 2020 &
2027

Table 58: Europe Current & Future Analysis for Organic Soy
Proteins by End-Use - Functional Foods, Infant Formula, Bakery &
Confectionery, Meat Alternatives and Dairy Alternatives -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 59: Europe Historic Review for Organic Soy Proteins by
End-Use - Functional Foods, Infant Formula, Bakery &
Confectionery, Meat Alternatives and Dairy Alternatives Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 60: Europe 15-Year Perspective for Organic Soy Proteins
by End-Use - Percentage Breakdown of Value Sales for Functional
Foods, Infant Formula, Bakery & Confectionery, Meat
Alternatives and Dairy Alternatives for the Years 2012, 2020 &
2027

FRANCE
Table 61: France Current & Future Analysis for Organic Soy
Proteins by Segment - Concentrates, Isolates and Flour -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 62: France Historic Review for Organic Soy Proteins by
Segment - Concentrates, Isolates and Flour Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 63: France 15-Year Perspective for Organic Soy Proteins
by Segment - Percentage Breakdown of Value Sales for
Concentrates, Isolates and Flour for the Years 2012, 2020 &
2027

Table 64: France Current & Future Analysis for Organic Soy
Proteins by End-Use - Functional Foods, Infant Formula, Bakery &
Confectionery, Meat Alternatives and Dairy Alternatives -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 65: France Historic Review for Organic Soy Proteins by
End-Use - Functional Foods, Infant Formula, Bakery &
Confectionery, Meat Alternatives and Dairy Alternatives Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 66: France 15-Year Perspective for Organic Soy Proteins
by End-Use - Percentage Breakdown of Value Sales for Functional
Foods, Infant Formula, Bakery & Confectionery, Meat
Alternatives and Dairy Alternatives for the Years 2012, 2020 &
2027

GERMANY
Table 67: Germany Current & Future Analysis for Organic Soy
Proteins by Segment - Concentrates, Isolates and Flour -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 68: Germany Historic Review for Organic Soy Proteins by
Segment - Concentrates, Isolates and Flour Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 69: Germany 15-Year Perspective for Organic Soy Proteins
by Segment - Percentage Breakdown of Value Sales for
Concentrates, Isolates and Flour for the Years 2012, 2020 &
2027

Table 70: Germany Current & Future Analysis for Organic Soy
Proteins by End-Use - Functional Foods, Infant Formula, Bakery &
Confectionery, Meat Alternatives and Dairy Alternatives -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 71: Germany Historic Review for Organic Soy Proteins by
End-Use - Functional Foods, Infant Formula, Bakery &
Confectionery, Meat Alternatives and Dairy Alternatives Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 72: Germany 15-Year Perspective for Organic Soy Proteins
by End-Use - Percentage Breakdown of Value Sales for Functional
Foods, Infant Formula, Bakery & Confectionery, Meat
Alternatives and Dairy Alternatives for the Years 2012, 2020 &
2027

ITALY
Table 73: Italy Current & Future Analysis for Organic Soy
Proteins by Segment - Concentrates, Isolates and Flour -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 74: Italy Historic Review for Organic Soy Proteins by
Segment - Concentrates, Isolates and Flour Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 75: Italy 15-Year Perspective for Organic Soy Proteins by
Segment - Percentage Breakdown of Value Sales for Concentrates,
Isolates and Flour for the Years 2012, 2020 & 2027

Table 76: Italy Current & Future Analysis for Organic Soy
Proteins by End-Use - Functional Foods, Infant Formula, Bakery &
Confectionery, Meat Alternatives and Dairy Alternatives -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 77: Italy Historic Review for Organic Soy Proteins by
End-Use - Functional Foods, Infant Formula, Bakery &
Confectionery, Meat Alternatives and Dairy Alternatives Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 78: Italy 15-Year Perspective for Organic Soy Proteins by
End-Use - Percentage Breakdown of Value Sales for Functional
Foods, Infant Formula, Bakery & Confectionery, Meat
Alternatives and Dairy Alternatives for the Years 2012, 2020 &
2027

UNITED KINGDOM
Table 79: UK Current & Future Analysis for Organic Soy Proteins
by Segment - Concentrates, Isolates and Flour - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 80: UK Historic Review for Organic Soy Proteins by
Segment - Concentrates, Isolates and Flour Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 81: UK 15-Year Perspective for Organic Soy Proteins by
Segment - Percentage Breakdown of Value Sales for Concentrates,
Isolates and Flour for the Years 2012, 2020 & 2027

Table 82: UK Current & Future Analysis for Organic Soy Proteins
by End-Use - Functional Foods, Infant Formula, Bakery &
Confectionery, Meat Alternatives and Dairy Alternatives -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 83: UK Historic Review for Organic Soy Proteins by
End-Use - Functional Foods, Infant Formula, Bakery &
Confectionery, Meat Alternatives and Dairy Alternatives Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 84: UK 15-Year Perspective for Organic Soy Proteins by
End-Use - Percentage Breakdown of Value Sales for Functional
Foods, Infant Formula, Bakery & Confectionery, Meat
Alternatives and Dairy Alternatives for the Years 2012, 2020 &
2027

SPAIN
Table 85: Spain Current & Future Analysis for Organic Soy
Proteins by Segment - Concentrates, Isolates and Flour -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 86: Spain Historic Review for Organic Soy Proteins by
Segment - Concentrates, Isolates and Flour Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 87: Spain 15-Year Perspective for Organic Soy Proteins by
Segment - Percentage Breakdown of Value Sales for Concentrates,
Isolates and Flour for the Years 2012, 2020 & 2027

Table 88: Spain Current & Future Analysis for Organic Soy
Proteins by End-Use - Functional Foods, Infant Formula, Bakery &
Confectionery, Meat Alternatives and Dairy Alternatives -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 89: Spain Historic Review for Organic Soy Proteins by
End-Use - Functional Foods, Infant Formula, Bakery &
Confectionery, Meat Alternatives and Dairy Alternatives Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 90: Spain 15-Year Perspective for Organic Soy Proteins by
End-Use - Percentage Breakdown of Value Sales for Functional
Foods, Infant Formula, Bakery & Confectionery, Meat
Alternatives and Dairy Alternatives for the Years 2012, 2020 &
2027

RUSSIA
Table 91: Russia Current & Future Analysis for Organic Soy
Proteins by Segment - Concentrates, Isolates and Flour -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 92: Russia Historic Review for Organic Soy Proteins by
Segment - Concentrates, Isolates and Flour Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 93: Russia 15-Year Perspective for Organic Soy Proteins
by Segment - Percentage Breakdown of Value Sales for
Concentrates, Isolates and Flour for the Years 2012, 2020 &
2027

Table 94: Russia Current & Future Analysis for Organic Soy
Proteins by End-Use - Functional Foods, Infant Formula, Bakery &
Confectionery, Meat Alternatives and Dairy Alternatives -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 95: Russia Historic Review for Organic Soy Proteins by
End-Use - Functional Foods, Infant Formula, Bakery &
Confectionery, Meat Alternatives and Dairy Alternatives Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 96: Russia 15-Year Perspective for Organic Soy Proteins
by End-Use - Percentage Breakdown of Value Sales for Functional
Foods, Infant Formula, Bakery & Confectionery, Meat
Alternatives and Dairy Alternatives for the Years 2012, 2020 &
2027

REST OF EUROPE
Table 97: Rest of Europe Current & Future Analysis for Organic
Soy Proteins by Segment - Concentrates, Isolates and Flour -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 98: Rest of Europe Historic Review for Organic Soy
Proteins by Segment - Concentrates, Isolates and Flour Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 99: Rest of Europe 15-Year Perspective for Organic Soy
Proteins by Segment - Percentage Breakdown of Value Sales for
Concentrates, Isolates and Flour for the Years 2012, 2020 &
2027

Table 100: Rest of Europe Current & Future Analysis for Organic
Soy Proteins by End-Use - Functional Foods, Infant Formula,
Bakery & Confectionery, Meat Alternatives and Dairy
Alternatives - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 101: Rest of Europe Historic Review for Organic Soy
Proteins by End-Use - Functional Foods, Infant Formula, Bakery &
Confectionery, Meat Alternatives and Dairy Alternatives
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 102: Rest of Europe 15-Year Perspective for Organic Soy
Proteins by End-Use - Percentage Breakdown of Value Sales for
Functional Foods, Infant Formula, Bakery & Confectionery, Meat
Alternatives and Dairy Alternatives for the Years 2012, 2020 &
2027

ASIA-PACIFIC
Table 103: Asia-Pacific Current & Future Analysis for Organic
Soy Proteins by Geographic Region - Australia, India, South
Korea and Rest of Asia-Pacific Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 104: Asia-Pacific Historic Review for Organic Soy
Proteins by Geographic Region - Australia, India, South Korea
and Rest of Asia-Pacific Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 105: Asia-Pacific 15-Year Perspective for Organic Soy
Proteins by Geographic Region - Percentage Breakdown of Value
Sales for Australia, India, South Korea and Rest of
Asia-Pacific Markets for Years 2012, 2020 & 2027

Table 106: Asia-Pacific Current & Future Analysis for Organic
Soy Proteins by Segment - Concentrates, Isolates and Flour -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 107: Asia-Pacific Historic Review for Organic Soy
Proteins by Segment - Concentrates, Isolates and Flour Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 108: Asia-Pacific 15-Year Perspective for Organic Soy
Proteins by Segment - Percentage Breakdown of Value Sales for
Concentrates, Isolates and Flour for the Years 2012, 2020 &
2027

Table 109: Asia-Pacific Current & Future Analysis for Organic
Soy Proteins by End-Use - Functional Foods, Infant Formula,
Bakery & Confectionery, Meat Alternatives and Dairy
Alternatives - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 110: Asia-Pacific Historic Review for Organic Soy
Proteins by End-Use - Functional Foods, Infant Formula, Bakery &
Confectionery, Meat Alternatives and Dairy Alternatives
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 111: Asia-Pacific 15-Year Perspective for Organic Soy
Proteins by End-Use - Percentage Breakdown of Value Sales for
Functional Foods, Infant Formula, Bakery & Confectionery, Meat
Alternatives and Dairy Alternatives for the Years 2012, 2020 &
2027

AUSTRALIA
Table 112: Australia Current & Future Analysis for Organic Soy
Proteins by Segment - Concentrates, Isolates and Flour -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 113: Australia Historic Review for Organic Soy Proteins
by Segment - Concentrates, Isolates and Flour Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 114: Australia 15-Year Perspective for Organic Soy
Proteins by Segment - Percentage Breakdown of Value Sales for
Concentrates, Isolates and Flour for the Years 2012, 2020 &
2027

Table 115: Australia Current & Future Analysis for Organic Soy
Proteins by End-Use - Functional Foods, Infant Formula, Bakery &
Confectionery, Meat Alternatives and Dairy Alternatives -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 116: Australia Historic Review for Organic Soy Proteins
by End-Use - Functional Foods, Infant Formula, Bakery &
Confectionery, Meat Alternatives and Dairy Alternatives Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 117: Australia 15-Year Perspective for Organic Soy
Proteins by End-Use - Percentage Breakdown of Value Sales for
Functional Foods, Infant Formula, Bakery & Confectionery, Meat
Alternatives and Dairy Alternatives for the Years 2012, 2020 &
2027

INDIA
Table 118: India Current & Future Analysis for Organic Soy
Proteins by Segment - Concentrates, Isolates and Flour -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 119: India Historic Review for Organic Soy Proteins by
Segment - Concentrates, Isolates and Flour Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 120: India 15-Year Perspective for Organic Soy Proteins
by Segment - Percentage Breakdown of Value Sales for
Concentrates, Isolates and Flour for the Years 2012, 2020 &
2027

Table 121: India Current & Future Analysis for Organic Soy
Proteins by End-Use - Functional Foods, Infant Formula, Bakery &
Confectionery, Meat Alternatives and Dairy Alternatives -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 122: India Historic Review for Organic Soy Proteins by
End-Use - Functional Foods, Infant Formula, Bakery &
Confectionery, Meat Alternatives and Dairy Alternatives Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 123: India 15-Year Perspective for Organic Soy Proteins
by End-Use - Percentage Breakdown of Value Sales for Functional
Foods, Infant Formula, Bakery & Confectionery, Meat
Alternatives and Dairy Alternatives for the Years 2012, 2020 &
2027

SOUTH KOREA
Table 124: South Korea Current & Future Analysis for Organic
Soy Proteins by Segment - Concentrates, Isolates and Flour -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 125: South Korea Historic Review for Organic Soy Proteins
by Segment - Concentrates, Isolates and Flour Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 126: South Korea 15-Year Perspective for Organic Soy
Proteins by Segment - Percentage Breakdown of Value Sales for
Concentrates, Isolates and Flour for the Years 2012, 2020 &
2027

Table 127: South Korea Current & Future Analysis for Organic
Soy Proteins by End-Use - Functional Foods, Infant Formula,
Bakery & Confectionery, Meat Alternatives and Dairy
Alternatives - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 128: South Korea Historic Review for Organic Soy Proteins
by End-Use - Functional Foods, Infant Formula, Bakery &
Confectionery, Meat Alternatives and Dairy Alternatives Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 129: South Korea 15-Year Perspective for Organic Soy
Proteins by End-Use - Percentage Breakdown of Value Sales for
Functional Foods, Infant Formula, Bakery & Confectionery, Meat
Alternatives and Dairy Alternatives for the Years 2012, 2020 &
2027

REST OF ASIA-PACIFIC
Table 130: Rest of Asia-Pacific Current & Future Analysis for
Organic Soy Proteins by Segment - Concentrates, Isolates and
Flour - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05957182/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Recommended Stories

  • Wall Street drops as tech stocks hit by spike in yields

    Wall Street's main indexes slipped on Tuesday as investors pulled out of heavyweight tech-related stocks and flocked to undervalued banks and industrial stocks amid a rise in U.S. bond yields. Apple Inc, Microsoft Corp, Amazon.com and Broadcom Inc dropped between 0.9% and 2.7%, as U.S. 10-year Treasury yield hit a 14-month high. The Nasdaq is set for its first monthly loss since November as a rise in yields since last month has particularly hit tech stocks which often have a low-rate environment heavily baked into their high valuations.

  • City of London expects most workers to return after pandemic

    The City of London financial centre, which has resembled a ghost town since the coronavirus swept the world last year, is likely to see most workers return to their offices after the pandemic, the City's political leader said on Tuesday. Catherine McGuinness, policy chair at the City of London Corporation, told BBC radio she was confident that trade would return for the cafes, pubs, restaurants and other businesses that rely on the usually teeming crowds of office workers. London dominates the world's $6.6 trillion-a-day foreign exchange market, it is the biggest centre for international banking and the second largest fintech hub in the world after the United States.

  • EUR/USD Price Forecast – Euro Continues to Look Soft

    The Euro continues to look soft as we have fallen a bit during the trading session on Monday. That being said, the market is choppy to say the least.

  • Block Trade Mess Revives Fierce Debate on ‘Leverage Gone Wrong’

    (Bloomberg) -- What might be the largest margin call in history is ringing fresh alarm bells on Wall Street among those worried about hidden leverage and its potential to fry the financial system.The forced selling of more than $20 billion of apparently swap-linked shares at Bill Hwang’s Archegos Capital Management has set off a hunt for other areas of excess -- from margin debt to options and bloated balance sheets -- after stocks at the center of the fiasco plunged and investment banks warned of losses.As with most things in markets, opinions vary: Hwang’s travails are portrayed as everything from phase one of a long-overdue market comeuppance, to an isolated case of risk-taking run amok. While Wall Street may have sidestepped a systemic cataclysm, the blowup is an example of “leverage gone wrong” with ominous portents, said Sameer Samana, Wells Fargo Investment Institute’s senior global market strategist.“What it does make me think of is how much leverage in aggregate has now built up in the system” in brokerage accounts, options and credit, Samana said. “If a broader stock market pullback were to take shape, especially in the more widely owned areas of technology and technology-related stocks, a much bigger unwind would have to take place.”On Monday, at least, the S&P 500 Index was barely registering the weekend’s tribulations, its 57% rally since March 2020 intact.Margin DebtIn recent weeks, as stocks vaulted to new highs, investors have pointed to a worrying trend at brokerages: ballooning margin debt, which at $813 billion at the end February stood at historically high levels (the numbers are reported on a delay). What’s sometimes lost in the discussion is that such debt almost always rises with the value of equities.“It would be common sense for one to look at this and say, we have a normal amount of margin debt in the system right now for where the market is,” said Arthur Hogan, chief market strategist at National Securities Corp. “I don’t know that that would have been a clear signal as to what’s going on in some of these media stocks and send a warning signal, because you would suspect that in a rising market the margin debt is going to be higher.”But not every lens into the phenomenon is reassuring, according to Jason Goepfert, president of Sundial Capital Research. Assuming that it will exceed $831 billion when this month’s numbers are reported in April, margin debt will have grown more than 70% year-over-year, one of the sharpest expansions since 1931. That means the year-over-year change in debt will have exceeded the year-over-year change in the S&P 500 by more than 20 percentage points for three months running.“This kind of excessive and persistent growth in debt, on both an absolute and relative level, has been a boogeyman for forward returns,” Goepfert wrote in a recent note to clients. “The most effective use of the data, both on the upside and downside, has been the rate of change, including relative to the S&P. And that’s why it’s becoming to be a much larger concern.”Options FrenzySpeculative mania in the options market has also fueled bubble warnings for the better part of a year. Call contracts -- in which bulls pay a fraction of a stock’s price to bet it will rise -- became the playthings of newly minted day traders, whose enthusiasm for short-dated options is theorized to have fueled a series of bullish feedback loops, particularly in tech stocks.“As you’re in a bull market with a lot of liquidity, you start to get some areas of overconfidence and some investors let their guard down,” said Keith Lerner, chief market strategist at Truist Advisory Services. “It does suggest a level of overconfidence.”However, that call volume has eroded from February’s peaks suggests some of the craze for the products is diminishing. Over the past 20 days, an average of over 23.6 million calls have traded on U.S. exchanges. While still historically high, that’s down from nearly 29 million in late February.Credit Risk Written OffCompanies that have loaded up on debt have been rewarded mightily in the equity market. Stocks in a basket defined by their high leverage have gained over 17% year-to-date, ranking them as the best-performers this year among 17 quantitative styles tracked by Bloomberg. On the other side of the trade, profitability is one of the worst-performing factors, with those shares nursing losses of over 5%.Goldman Sachs Group Inc. data tells a similar story: S&P 500 firms with weak balance sheets are on track to beat out those with sturdier finances by over 17 percentage points this quarter -- the biggest margin of outperformance since at least 2006.Taken together, such statistics can be used to paint a picture of a market so frothy that investors are willing to disregard any qualms over credit risk. But it’s also true that those companies -- among the hardest hit by the coronavirus -- stand to benefit the most from the so-called reopening trade as vaccines are given and economic activity picks up. Along with the combined might of governmental fiscal aid and the Federal Reserve’s seemingly endless bond-buying, the stock market’s weakest links can have the biggest bounce.“These were the companies where investors were most concerned about not surviving, so they tend to get a relief rally,” said Truist’s Lerner. “Having the Fed with so much monetary stimulus and support makes investors more confident this won’t become systemic.”High Hedge Fund LeverageIt’s not just Hwang’s Archegos that loaded up on borrowed money to make trades. Average leverage across the 10 largest hedge funds clocked in at 15.9 as of June 2020, according to data from the Treasury Department’s Office of Financial Research. While that figure is down from a peak of 24.6 in June 2019, it’s far above the 5 average for the next 40 largest funds.That number dwarfs the amount of leverage Hwang was operating with. Market participants estimate that the family office’s total assets had grown to anywhere between $5 billion to $10 billion, while total positions may have topped $50 billion.But while the biggest hedge funds may have more leverage than Archegos outright, it’s important to consider what those funds are leveraged to, according to Bespoke Investment Group’s George Pearkes. For example, concentrating a smaller amount of leverage to handful of stocks is much riskier than putting a bigger amount of borrowed money in instruments like Treasuries or currencies, he said.“If an asset is less volatile, more leverage can be applied safely,” said Pearkes, a global macro strategist at the firm. “And that’s generally what’s going on with larger funds.”For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Analysis: With stick and carrot, Saudi starts winning over firms in regional race

    When CSG opted to shift its regional headquarters this year from Dubai to Riyadh, it marked an early win for Saudi Arabia and proved a surprisingly easy move for the U.S. technology firm: the new office was up and running in just two months. CSG is among several foreign companies that agreed earlier this year to set up regional offices in Saudi Arabia rather than overseeing operations remotely from Dubai, the buzzing commercial hub in neighbouring United Arab Emirates.

  • Biden administration threatens tariffs on UK goods in 'tech tax' row

    Ceramics, make-up and furniture could be hit amid a row over a new UK tax on tech firms.

  • No IRS stimulus check? If you haven't gotten the third COVID relief payment, you're not completely out of luck

    Nearly 30 million Social Security and SSI beneficiaries are still waiting for stimulus check money, according to House Democrats.

  • Exclusive: India freezes bank accounts of China's ByteDance in tax case, company mounts challenge - sources

    Indian authorities have blocked bank accounts of ByteDance in the country for alleged tax evasion and the company has asked a court to quash the directive which it fears will hit its operations hard, two sources with direct knowledge told Reuters. ByteDance in January cut its India workforce after New Delhi decided to retain a ban on its popular video app TikTok, first prohibited last year following a border clash between India and China. China has repeatedly criticized India's move and said it suspected it was against WTO rules.

  • Here's why Wall Street is terrified over 'Tiger Cub's' surprise portfolio blowup

    Wall Street is looking over their backs following the portfolio blowup of whale Bill Hwang.

  • Behind the Archegos Meltdown: How Banks Quickly Got Religion about Bill Hwang

    By John Jannarone Last week’s block trade mayhem can now be connected with a highly levered hedge fund that faced unmet margin calls and likely cost Wall Street banks several billion dollars in losses. But the real question is whether the unraveling – that started a few days earlier – poses serious risk to the […]

  • S&P 500 ends a hair lower; hedge fund default concerns hit banks

    The S&P 500 ended just slightly in the red on Monday, with bank shares falling amid warnings of potential losses from a hedge fund's default on margin calls, while optimism over the economy limited the day's declines. The Dow ended higher, with shares of planemaker Boeing Co rising 2.3% after the company reached a deal with U.S. budget carrier Southwest Airlines Co for a variant of the 737 MAX aircraft. Nomura and Credit Suisse are facing billions of dollars in losses after a U.S. hedge fund, named by sources as Archegos Capital, defaulted on margin calls, putting investors on edge about who else might have been caught out.

  • China May Boost Cotton Imports to Cut Xinjiang Fiber in Exports

    (Bloomberg) -- China could import more cotton to replace fiber from Xinjiang that’s being rejected by some Western companies and threatens to hurt its booming textile export industry.The U.S. bans entry of all products containing cotton from Xinjiang, which accounts for over 80% of China’s output, because of concern over the human rights situation in the region. Hennes & Mauritz AB, Nike Inc. and Adidas AG have become ensnared in the row, drawing consumer ire in China for pledges not to use cotton from the area, a major supplier in the global supply chain.“The only option right now may be to increase cotton imports as export orders for some textile mills will suffer if they use local fiber,” said Xu Yaguang, an analyst with Huatai Futures. Xu sees so-called extra cotton import quotas this year returning to the 2019 level of 800,000 tons with an increased requirement for high-quality fiber. The government issued 400,000 tons of extra quotas in 2020, and has not so far issued any for 2021.Consumption of Xinjiang cotton could drop by as much as 20% as the export outlook for products containing cotton from the region is not very bright, said Wu Faxin, a veteran cotton trader with industry portal shaxianbao.cn. Wu expects exporting countries such as Brazil and those in Africa to benefit from the additional demand.Wu Yan, head of the Better Cotton Initiative (BCI) in China, told state television the decision by its headquarters to cut ties with Xinjiang growers will block about 500,000 tons of fiber from the region from entering the global supply chain. The group in China said it has not found any forced labor in Xinjiang since 2012. Members include world retailers and brands such as H&M and Nike.Job CutsSome cotton yarn factories in Xinjiang are cutting employees because of poor sales after some global brands chose not to source cotton and yarn from the region, the China Daily reported Monday, citing a local official. Suppliers of the retail brands no longer place orders with local producers. “The real victims of the false accusations of ‘forced labor’ in Xinjiang are the large numbers of vulnerable cotton growers and textile workers,” it said.Some analysts also doubt that the U.S. can effectively test for Xinjiang cotton in every shipment of textile products. Apart from exporting finished goods, top textile shipper China also sends intermediate products to third countries. Vietnam, for example, sources 50% of its cotton yarn from China and more than 60% of its cotton cloth, according to Huatai’s Xu.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • EU fines Moody's for failing to disclose conflicts of interests

    All the breaches resulted from negligence on the part of the company, the European Securities and Markets Authority (ESMA) said, adding that the fine was for five Moody's entities based in France, Germany, Italy, Spain and Britain. ESMA said Moody's had inadequate internal policies and procedures to manage shareholder conflicts of interest. "ESMA found that MIS (Moody's Investors Service) had no intent to infringe the EU regulation and there was no impact on the quality of any ratings," a Moody's spokesperson said in an e-mailed statement to Reuters.

  • Stock market news live updates: Stocks mixed as Archegos margin call ricochets across markets; Suez ship freed

    Stocks are giving back gains after a strong week, with little seen moving the needle before March's jobs data.

  • Cathie Wood’s ETFs Ditch Ownership Caps, Add SPAC Warning

    (Bloomberg) -- Cathie Wood has spent months defending Ark Investment Management from critics who say the money manager has too much cash tied up in too few stocks. The firm’s latest move is handing them fresh ammunition.In a filing late last week, Ark altered the prospectuses for its exchange-traded funds to remove clauses limiting its exposure and concentration risks.The changes eliminate a 30% cap on how much of each fund’s assets could be invested in the securities of a single entity, and a 20% limit on the amount of a company’s shares an ETF could own.It also introduced language acknowledging funds may buy into blank-check firms and noting the risks of buying shares in special-purpose acquisition companies that haven’t yet decided what businesses they’ll own. The ARK Autonomous Technology & Robotics ETF (ticker ARKQ) last week bought shares of a SPAC backed by tennis star Serena Williams.These are eye-catching changes for Ark, founded by Wood in 2014. Concerns have swirled around the New York-based firm in recent months after a stellar year saw ETF assets surge at one point to more than $60 billion. Ark invests in companies involved with disruptive trends, which mean it has a limited pool of targets in which to deploy that money.“It seems like they’re willing to take on more single-stock risk if they truly believe in a company,” said Mohit Bajaj, director of ETFs for WallachBeth Capital. “It’s truly active management.”Testing the LimitIn February as its flagship product, the Ark Innovation ETF (ARKK), peaked, the firm controlled 20% or more of at least three companies, according to data compiled by Bloomberg. This was spread across several funds, so didn’t yet test the 20% cap that’s now removed from prospectuses.In addition to deleting the general limits, the March 26 filing removed caps on ownership of depositary receipts, rights, warrants, preferred securities and convertibles.A representative for Ark didn’t immediately respond to a request for comment.The adjustments come on the eve of Ark’s first new ETF launch in two years. The ARK Space Exploration ETF (ARKX) is due to begin trading on Tuesday, according the firm’s website.In a nod to the kinds of concentration risk some investors fret about, the new ETF’s second-biggest holding will actually be another Wood product -- 6.1% of the fund will be invested in Ark’s 3D Printing ETF (PRNT).“When you have a situation where the risk is concentrated and there is a lot of leverage in the system, it creates even bigger risks,” said Matt Maley, chief market strategist at Miller Tabak + Co.(Updates with ARKX fund information in final paragraphs, analyst comment)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Malaysia's AirAsia shares slide after record quarterly loss

    Shares in AirAsia Group Bhd fell in morning trade on Tuesday, as analysts lowered earnings forecasts after the Malaysian budget airline group posted its record quarterly loss. Affin Hwang Capital cut earnings forecasts for 2021 and 2022, expecting a larger net loss this year due to lockdowns in Malaysia in the first quarter, closed borders and longer-than-expected timeframe for the COVID-19 immunisation programme. "We now anticipate AirAsia to report net loss of 92 million ringgit in 2022 due to slower-than-expected recovery in international tourism," analyst Isaac Chow said in his note.

  • US STOCKS-S&P 500 near flat; hedge fund default concerns hit banks

    The S&P 500 was nearly flat in Monday afternoon trading, with bank shares falling amid warnings of potential losses from a hedge fund's default on margin calls, while optimism over the economy limited the day's declines. The Dow was higher, with shares of planemaker Boeing Co up 1.9% after the company reached a deal with U.S. budget carrier Southwest Airlines Co for a variant of the 737 MAX aircraft.

  • Billions in Secret Derivatives at Center of Archegos Blowup

    (Bloomberg) -- The forced liquidation of more than $20 billion in holdings linked to Bill Hwang’s investment firm is drawing attention to the covert financial instruments he used to build large stakes in companies.Much of the leverage used by Hwang’s Archegos Capital Management was provided by banks including Nomura Holdings Inc. and Credit Suisse Group AG through swaps and so-called contracts-for-difference, according to people with direct knowledge of the deals. It means Archegos may never actually have owned most of the underlying securities -- if any at all.While investors who own a stake of more than 5% in a U.S.-listed company usually have to disclose their holdings and subsequent transactions, that’s not the case with positions built through the type of derivatives apparently used by Archegos. The products, which are transacted off exchanges, allow managers like Hwang to amass exposure to publicly-traded companies without having to declare it.The swift unwinding of Archegos has reverberated across the globe, after banks such as Goldman Sachs Group Inc. and Morgan Stanley forced Hwang’s firm to sell billions of dollars in investments accumulated through highly leveraged bets. The selloff roiled stocks from Baidu Inc. to ViacomCBS Inc., and prompted Nomura and Credit Suisse to disclose that they face potentially significant losses on their exposure.One reason for the widening fallout is the borrowed funds that investors use to magnify their bets: a margin call occurs when the market goes against a large, leveraged position, forcing the hedge fund to deposit more cash or securities with its broker to cover any losses. Archegos was probably required to deposit only a small percentage of the total value of trades.The chain of events set off by this massive unwinding is yet another reminder of the role that hedge funds play in the global capital markets. A hedge fund short squeeze during a Reddit-fueled frenzy for Gamestop Corp. and other shares earlier this year spurred a $6 billion loss for Gabe Plotkin’s Melvin Capital and sparked scrutiny from U.S. regulators and politicians.The idea that one firm can quietly amass outsized positions through the use of derivatives could set off another wave of criticism directed against loosely regulated firms that have the power to destabilize markets.While the margin calls on Friday triggered losses of as much as 40% in some shares, there was no sign of contagion in markets broadly on Monday. Contrast that with 2008, when Ireland’s then-richest man used derivatives to build a position so large in Anglo Irish Bank Corp. it eventually contributed to the country’s international bailout. In 2015, New York-based FXCM Inc. needed rescuing because of losses at its U.K. affiliate resulting from the unexpected de-pegging of the Swiss franc.Much about Hwang’s trades remains unclear, but market participants estimate his assets had grown to anywhere from $5 billion to $10 billion in recent years and total positions may have topped $50 billion.“This is a challenging time for the family office of Archegos Capital Management, our partners and employees,” Karen Kessler, a spokesperson for Archegos, said late Monday in an emailed statement. “All plans are being discussed as Mr. Hwang and the team determine the best path forward.”CFDs and swaps are among bespoke derivatives that investors trade privately between themselves, or over-the-counter, instead of through public exchanges. Such opacity helped to worsen the 2008 financial crisis and regulators have introduced a vast new body of rules governing the assets since then.Over-the-counter equity derivatives occupy one of the smallest corners of this opaque market. Swaps and forwards linked to stocks had a gross market value of $282 billion at the end of June 2020, according to data from the Bank for International Settlements. That compared with $10.3 trillion for swaps linked to interest rates and $2.4 trillion for swaps and forwards linked to currencies.Regulators have begun clamping down on CFDs in recent years because they’re concerned the derivatives are too complex and too risky for retail investors, with the European Securities and Markets Authority in 2018 restricting the distribution to individuals and capping leverage. In the U.S., CFDs are largely banned for amateur traders.Banks still favor them because they can make a large profit without needing to set aside as much capital versus trading actual securities, another consequence of regulation imposed in the aftermath of the global financial crisis. Among hedge funds, equity swaps and CFDs grew in popularity because they are exempt from stamp duty in high-tax jurisdictions such as the U.K.(Updates with Archegos comment in 10th paragraph, clarifies language used to describe trade structure in third paragraph and expands tout box.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Nomura flags $2 billion loss, cancels bond issue; shares plummet

    TOKYO (Reuters) -Nomura Holdings Inc on Monday flagged a possible $2 billion loss at a U.S. subsidiary, prompting Japan's biggest brokerage and investment bank to shelve a hefty bond issuance and sending its stock tumbling by the most in over a decade. Nomura's stock was greeted by a deluge of sell orders at market open, pushing its price down as much 16% in early trade. The trades were linked to sales of holdings by Archegos Capital Management, a person with knowledge of the matter told Reuters.

  • What's ahead for the all-time high stock market?

    Top news and what to watch in the markets on Monday, March 29, 2021.